The 'Parkinson's Patch'
Researchers are developing a new method for treating patients with Parkinson's disease. The 'Parkinson's Patch' assures a steady, uniform dosage of medication, thereby reducing the risk of side effects
Friday, September 20, 2002
print
|
email
|
One of the chronic problems for people suffering from Parkinson's
disease is ensuring that the levels of medication to treat the
symptoms of the condition are consistent and uniform. When dosage
levels fluctuate, the result can sometimes be ineffective treatment
and negative side effects. Burton Scott, assistant clinical
professor in neurology at the Movement Disorders Clinic at Duke
University Medical Center, says many new and innovative approaches
to treating the disease are on the horizon, including the
"Parkinson's Patch." Scott says the
patch is currently in the final stage of clinical trials and could
be approved by the FDA within three years. He says the device could
simplify the lives of Parkinson's patients. I'm Cabell Smith for MedMinute.
Note: To obtain information about clinical trials for
Parkinson's disease at the Duke Movement Disorders Clinic, contact
Carroll Wilcox, RN, at (919) 668-2879.
